Absci Corporation (ABSI)
Largest Insider Buys in Sector
ABSI Stock Price History Chart
ABSI Stock Performance
About Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Insider Activity of Absci Corporation
Over the last 12 months, insiders at Absci Corporation have bought $999,999 and sold $13.74M worth of Absci Corporation stock.
On average, over the past 5 years, insiders at Absci Corporation have bought $27.22M and sold $13.74M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Redmile Group, LLC (director) — $11M.
The last purchase of 222,222 shares for transaction amount of $999,999 was made by Redmile Group, LLC (director) on 2024‑03‑01.
List of Insider Buy and Sell Transactions, Absci Corporation
| 2024-06-13 | Sale | CFO / CBO | 19,859 0.0194% | $4.98 | $98,892 | -8.92% | ||
| 2024-05-22 | Sale | 10 percent owner | 3.1M 2.6164% | $4.40 | $13.64M | -12.55% | ||
| 2024-03-01 | director | 222,222 0.1982% | $4.50 | $999,999 | -20.18% | |||
| 2022-02-09 | General Counsel | 4,250 0.0044% | $7.96 | $33,830 | -59.91% | |||
| 2022-01-20 | VP, CCPAO | 2,000 0.0023% | $7.50 | $15,000 | -50.42% | |||
| 2022-01-19 | President and Chief Executive | 7,155 0.0081% | $6.92 | $49,513 | -47.79% | |||
| 2021-07-26 | director | 1.88M 1.7426% | $16.00 | $30M | -63.43% | |||
| 2021-07-26 | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | |||
| 2021-07-26 | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | |||
| 2021-07-26 | President and Chief Executive | 600 0.0006% | $16.00 | $9,600 | -63.43% | |||
| 2021-07-26 | director | 15,000 0.0139% | $16.00 | $240,000 | -63.43% | |||
| 2021-07-26 | General Counsel | 10,000 0.0093% | $16.00 | $160,000 | -63.43% | |||
| 2021-07-26 | director | 9,000 0.0084% | $16.00 | $144,000 | -63.43% | |||
| 2021-07-26 | VP, CCPAO | 1,000 0.0009% | $16.00 | $16,000 | -63.43% |
Insider Historical Profitability
| Redmile Group, LLC | director | 8253316 7.1858% | $2.67 | 2 | 0 | <0.0001% |
| Jonasson Zachariah | CFO / CBO | 384751 0.335% | $2.67 | 1 | 1 | <0.0001% |
| Casdin Eli | director | 6745333 5.8729% | $2.67 | 1 | 0 | <0.0001% |
| Casdin Partners Master Fund, L.P. | director | 6745333 5.8729% | $2.67 | 1 | 0 | <0.0001% |
| McClain Sean | President and Chief Executive | 6368955 5.5452% | $2.67 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $84.12M | 13.1 | 14.81M | +6.85% | +$5.39M | 0.01 | |
| Redmile Group | $46.88M | 7.3 | 8.25M | +2.77% | +$1.26M | 0.48 | |
| Alger | $42.08M | 6.55 | 7.41M | New | +$42.08M | 0.21 | |
| The Vanguard Group | $19.57M | 3.05 | 3.45M | +33.74% | +$4.94M | <0.0001 | |
| ARK Investment Management LLC | $18.61M | 2.9 | 3.28M | New | +$18.61M | 0.06 |